about
Selective splenic artery embolization for the treatment of thrombocytopenia and hypersplenism in paroxysmal nocturnal hemoglobinuria.Microwave ablation (MWA) for the treatment of a solitary, chemorefractory testicular cancer liver metastasis.Angiographic identification of extrahepatic perfusion after hepatic arterial pump placement: implications for surgical prevention.Ki-67 is a prognostic biomarker of survival after radiofrequency ablation of liver malignanciesDiagnostic imaging approaches and relationship to hepatobiliary cancer staging and therapy.Image-guided thermal ablation of tumors increases the plasma level of interleukin-6 and interleukin-10.CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy.Pattern of retained contrast on immediate postprocedure computed tomography (CT) after particle embolization of liver tumors predicts subsequent treatment response.Locoregional Therapy for Hepatocellular Carcinoma with and without Extrahepatic SpreadComparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm.Percutaneous Preoperative Biliary Drainage for Resectable Perihilar Cholangiocarcinoma: No Association with Survival and No Increase in Seeding Metastases.Particle embolization of recurrent hepatocellular carcinoma after hepatectomy.Recognition of intrabiliary hepatic metastases from colorectal adenocarcinoma.Interreader and inter-test agreement in assessing treatment response following transarterial embolization for hepatocellular carcinomaPancreatic neuroendocrine tumor with aneurysms of the gastroduodenal artery: a case reportPyogenic abscess after hepatic artery embolization: a rare but potentially lethal complication.Percutaneous transhepatic biliary drainage.Management of malignant biliary obstruction.Histopathologic and immunohistochemical features of tissue adherent to multitined electrodes after RF ablation of liver malignancies can help predict local tumor progression: initial results.Embolization of metastatic neuroendocrine tumor resulting in clinical manifestations of syndrome of inappropriate secretion of antidiuretic hormone.Timing of administration of bevacizumab chemotherapy affects wound healing after chest wall port placement.A phase 1 dose-escalation study of irinotecan in combination with 17-allylamino-17-demethoxygeldanamycin in patients with solid tumors.High-grade neuroendocrine carcinoma of the colon, long-term survival in advanced disease.Catheter-free survival after primary percutaneous stenting of malignant bile duct obstruction.Arterially directed therapies for hepatocellular carcinoma.Totally implantable venous access device placement by interventional radiologists: are prophylactic antibiotics necessary?Percutaneous ablation of peribiliary tumors with irreversible electroporation.Factors affecting periprocedural morbidity and mortality and long-term patient survival after arterial embolization of hepatic neuroendocrine metastases.Hepatic artery embolization for liver metastasis of gastrointestinal stromal tumor following imatinib and sunitinib therapy.Hepatic arterial embolization complicated by acute cholecystitis.Catheter-directed endovascular application of thrombin: Report of 3 cases and review of the literature.Variant hepatic arterial anatomy revisited: digital subtraction angiography performed in 600 patients.Cystic artery localization with a three-dimensional angiography vessel tracking system compared with conventional two-dimensional angiography.Pylephlebitis and liver abscess mimicking hepatocellular carcinoma.Challenges in combining antiangiogenic therapy with transarterial chemoembolization for hepatocellular carcinoma.Resolution of hepatic encephalopathy following hepatic artery embolization in a patient with well-differentiated neuroendocrine tumor metastatic to the liver.Arterial patency after repeated hepatic artery bland particle embolization.Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma.Fatal pulmonary complications after arterial embolization with 40-120- micro m tris-acryl gelatin microspheres.A phase II trial of isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft tissue sarcoma of the extremity.
P50
Q33414246-9047A359-6290-433C-A495-8E42642C0502Q33415967-4AB60F2A-629A-43CF-97DE-3C945EEF2A6DQ33960732-6DC33034-0BC1-432D-B5DA-65C88959A4F0Q34003699-2A3DADC8-2E4E-4801-9ADB-F060E78EA429Q34111000-9EFFC04E-1A25-4842-8D01-6F2156DCD719Q34205626-BE198002-5A8B-443F-973F-BEEC1E8E8FD7Q35059732-7968BA9F-5D13-4853-B2FE-0CC82824AA0DQ35383390-8C7DF73A-57B2-4F00-BB48-9DA1E18618C9Q35951070-F110B14C-D00F-4BCA-8CBA-625E1221532AQ36185946-D363741D-6BB6-4616-A232-74BA4F86FD0BQ36391818-B07DCAC2-AFF4-49B7-98D3-F95F9F8F799AQ36441150-23DD8422-CD1E-4427-89AC-03003BBF6801Q36713155-3A2BF069-EF9E-43B2-BC2E-8B0169679C1AQ37143017-CF7C8CDC-6447-4265-B718-F6BD09910462Q37186752-683AD220-8157-452C-AB83-3098E838A7EFQ37209714-D5CD3550-1C49-4260-A786-D1D91539DC6CQ37251413-CAF3715C-2620-425D-8F02-5148BCA62441Q37251419-75DF0DFF-48E0-4E4E-81A5-C779E614A2E9Q37271084-D54F522A-6338-4ED4-B017-2EAD5A0EE033Q37343734-8B67A457-77DF-466F-894C-5015ADB02E1AQ37406167-F84336E8-C9B8-42F1-8334-B7C1A8D7EAEEQ37718291-2ED7279D-FE39-4C49-BBC6-98FBCFCF516EQ37788615-007DADF4-159C-44CA-B3E0-785B76D395BCQ37921566-BAFC5483-86EC-4E39-AA15-5DDAB0378ABBQ37937274-10351D1B-0FD3-468C-B771-0F5F2FB1EA44Q37988126-412742CE-CA89-4658-92A4-2BFAC9883A8CQ38164855-D98ECA86-853C-4D4E-B4C1-D036EFA2277CQ38173590-B7CEB1A9-EBDD-48BD-8852-49D1D0A814DFQ38263998-1370CCC8-5EAE-4A82-820E-CFE9CB844BB9Q38704615-6111BC5E-941C-41E3-BE3E-5A4D6856F98AQ39034309-CED66ED6-C462-4A80-98F9-F8E65042D124Q39609899-E96A2050-6D24-40F3-BC52-42A46D9E1178Q39981956-5EC73660-F1C3-4F81-A752-4D2EF066ED42Q40546827-715B3568-1BE6-44C7-92E4-377A7924247AQ41851928-CBE89404-7C67-40BD-9D06-2A9076BF6C9EQ42263781-8A8E2823-CF82-4B7E-A36E-6E19E2649FCBQ43147861-300A3FE2-EC17-4623-9C22-7FFAC2B61950Q43419259-9092A8B9-4B32-4F63-8ECC-E937D4D23573Q44764361-981915B9-34EE-4683-AA10-8E9237063C60Q48687655-CAD763A1-4BEA-44EC-AA4C-B45C3039AF51
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Karen T Brown
@nl
Karen T Brown
@sl
Karen T. Brown
@en
Karen T. Brown
@es
type
label
Karen T Brown
@nl
Karen T Brown
@sl
Karen T. Brown
@en
Karen T. Brown
@es
prefLabel
Karen T Brown
@nl
Karen T Brown
@sl
Karen T. Brown
@en
Karen T. Brown
@es
P106
P1153
55031916500
P21
P31
P496
0000-0003-2434-0037